Myeloid-derived suppressor cells and their role in CTLA-4 blockade therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 9, p. 977, doi. 10.1007/s00262-014-1570-7
- By:
- Publication type:
- Article
Works matching IS 03407004 AND DT 2014 AND VI 63 AND IP 9
Results: 12
1
2
Intrinsically de-sialylated CD103 CD8 T cells mediate beneficial anti-glioma immune responses.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 9, p. 911, doi. 10.1007/s00262-014-1559-2
- By:
- Publication type:
- Article
3
Generation and characterization of a novel human IgG1 antibody against vascular endothelial growth factor receptor 2.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 9, p. 877, doi. 10.1007/s00262-014-1560-9
- By:
- Publication type:
- Article
4
The microtubule-depolymerizing agent ansamitocin P3 programs dendritic cells toward enhanced anti-tumor immunity.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 9, p. 925, doi. 10.1007/s00262-014-1565-4
- By:
- Publication type:
- Article
5
Phase II clinical trial of ex vivo-expanded cytokine-induced killer cells therapy in advanced pancreatic cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 9, p. 939, doi. 10.1007/s00262-014-1566-3
- By:
- Publication type:
- Article
6
The anti-lymphoma activities of anti-CD137 monoclonal antibodies are enhanced in FcγRIII mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 9, p. 947, doi. 10.1007/s00262-014-1567-2
- By:
- Publication type:
- Article
7
Preclinical evaluation of IL2-based immunocytokines supports their use in combination with dacarbazine, paclitaxel and TNF-based immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 9, p. 901, doi. 10.1007/s00262-014-1562-7
- By:
- Publication type:
- Article
8
Bioactive compounds or metabolites from black raspberries modulate T lymphocyte proliferation, myeloid cell differentiation and Jak/STAT signaling.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 9, p. 889, doi. 10.1007/s00262-014-1564-5
- By:
- Publication type:
- Article
9
Engineered T cells for cancer therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 9, p. 969, doi. 10.1007/s00262-014-1568-1
- By:
- Publication type:
- Article
10
Foxp3 expression in T regulatory cells and other cell lineages.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 9, p. 869, doi. 10.1007/s00262-014-1581-4
- By:
- Publication type:
- Article
11
'Immunotherapy of cancer: present status and future promise': Danish Cancer Society Symposium, Copenhagen, Denmark, 23rd-25th September 2013.
- Published in:
- 2014
- By:
- Publication type:
- Report
12
Optimized dendritic cell-based immunotherapy for melanoma: the TriMix-formula.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 9, p. 959, doi. 10.1007/s00262-014-1558-3
- By:
- Publication type:
- Article